Dr Katarzyna Szoltysek Dr Carmela Ciardullo Dr Peixun Zhou Dr Anna Walaszczyk Dr Elaine Willmore et al. | Dap kinase-related apoptosis-inducing protein kinase 2 (Drak2) is a key regulator and molecular marker in chronic lymphocytic leukemia | 2020 |
|
Dr Carmela Ciardullo Erhan Aptullahoglu Dr Laura Woodhouse Dr Wei-Yu Lin Dr Jonathan Wallis et al. | Non-genotoxic MDM2 inhibition selectively induces pro-apoptotic p53 gene signature in chronic lymphocytic leukemia cells | 2019 |
|
Dr Carmela Ciardullo Dr Elaine Willmore Dr Amir Enshaei Dr Peixun Zhou Dr Vikki Rand et al. | BACH2 and BCL6 Cooperatively Fuction as Tumour Suppressors in CLL | 2016 |
|
Dr Carmela Ciardullo
| Clinical impact of small subclones harboring NOTCH1, SF3B1 or BIRC3 mutations in chronic lymphocytic leukemia. | 2016 |
|
Dr Carmela Ciardullo Dr Elaine Willmore Dr Peixun Zhou Dr Vikki Rand Professor Christine Harrison FRCPath FMedSci et al. | Impact of the apoptotic regulator DRAK2 in chronic lymphocytic leukemia | 2016 |
|
Dr Carmela Ciardullo Dr Peixun Zhou Dr Elaine Willmore Professor Christine Harrison FRCPath FMedSci Dr Andrew Hall et al. | Impact of the apoptotic regulator DRAK2 in chronic lymphocytic leukemia | 2016 |
|
Dr Carmela Ciardullo Dr Stuart Bennett Professor Mark Walker
| Rosiglitazone improves insulin sensitivity, glucose tolerance and ambulatory blood pressure in subjects with impaired glucose tolerance: Does it really work? If yes, is it a novelty? | 2005 |
|